Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $5.1452W HIGH $3,390.00
Volume
155.97 K
Value Traded
77.27 K
Short % Float
10.54%
Days to Cover
1.0
-29.68%Week
-60.37%1 Month
-76.42%3 Month
-89.12%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
4.55 M
EPS (TTM)
-19.20
P/E Ratio
-
Ent. Value
16.11 M
Total Shares
886.50 K
Float Shares
120.00 K
Insiders
86.22%
Institutions
0.24%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
HCTI Catalyst Timeline
Dated clinical, regulatory and corporate events for Healthcare Triangle, Inc.
Past FDA Catalysts and PDUFA Decisions
How HCTI actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Healthcare Triangle, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every HCTI program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| VENKATACHARI SURESHDirector, Officer (Chief Executive Officer), 10% Owner | Grant/Award | 6,000 6,000 held | $0.00 | 07/12/2021 |
Hedge Fund 13F Activity
Hedge Funds invested in HCTI
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in HCTI for Q2 2026. | ||||
Ownership Trends
HCTI Short Interest
Shares sold short, counted twice a month.
10.54%
Short % of Float
of tradable shares sold short
252.9K
Shares Sold Short
-67.0% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
411.6K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How HCTI ranks across every disease it competes in
Competitive Position is a premium feature
See how HCTI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialHCTI News
-HCTI
Nov 2, 2026▼ -0.2%today
Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
Healthcare Triangle, Inc. announced its expansion into Indonesia through Quantum Nexis, identifying a potential USD 45 million business opportunity. The company is targeting various sectors, including hospitals and government wellness programs, with its digital health platforms. Engagements are ongoing, with no definitive agreements yet signed.
Read more →-HCTI
Oct 26, 2026Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Healthcare Triangle, Inc. (HCTI) announced the launch of Neurotechnology AI Devices through its subsidiary Quantum Nexis in Malaysia and Indonesia. This initiative aims to address the growing mental health needs of over 310 million people in the region. The project includes device sales, professional training, and AI software subscriptions, with a focus on local manufacturing and education.
Read more →-HCTI
Oct 22, 2026▼ -8.8%on this news· ran to -19% by day 1shared move
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan
Healthcare Triangle, Inc. announced a 1-for-20 reverse stock split effective October 26, 2026. This move aims to increase the share price and comply with Nasdaq's $1.00 minimum bid requirement. The number of outstanding shares will decrease from approximately 17.7 million to about 886,501 shares.
Read more →-HCTI
Oct 20, 2026▲ +8.1%on this newsshared move
HCTI Expands AI Business with 6 New Contracts, Targeting approx. $4.65M in Annual Run Rate Revenue
Healthcare Triangle, Inc. (HCTI) has announced six new client engagements through its Teyame business, projected to generate an estimated $1.34 million in annual revenue. An additional unsigned opportunity could increase this figure to approximately $4.65 million. The contracts involve various services for well-known insurance companies, with operations set to begin in late 2026.
Read more →-HCTI
Sep 30, 2026Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America
Healthcare Triangle, Inc. (HCTI) has signed a Memorandum of Understanding with AI World Sdn. Bhd. to create a joint venture focused on deploying AI-enabled humanoid nursing robots in North American hospitals. The robots aim to assist with patient hygiene care, alleviating the workload on nursing staff. HCTI will leverage its extensive hospital network to bring the technology to market, pending regulatory approvals.
Read more →-HCTI
Sep 23, 2026▲ +5.4%on this news
Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business
Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent to acquire Roboticom, a provider of industrial robotic automation systems. The acquisition aims to expand HCTI's technology platform into industrial automation, potentially enhancing its competitive position by integrating AI capabilities. However, the financial projections provided by Roboticom are unaudited and subject to significant uncertainty.
Read more →-HCTI
Sep 17, 2026Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies
Healthcare Triangle, Inc. (HCTI) has partnered with ARCB Investment LLC and Kanzun Ventures to establish a growth fund aimed at facilitating the entry of Malaysian healthcare companies into U.S. capital markets. HCTI will leverage its technology and market experience to prepare these companies for expansion. The partnership seeks to bridge the gap between Malaysian healthcare entrepreneurs and international capital.
Read more →-HCTI
Sep 3, 2026Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.
Healthcare Triangle, Inc. (HCTI) has approved a stock dividend distribution of a minority interest in Teyame AI Holdings Inc. to its shareholders. This move is part of a planned direct listing of Teyame AI Holdings on NASDAQ, which is subject to regulatory approval. The separation agreement outlines the allocation of assets and liabilities between HCTI and Teyame AI Holdings.
Read more →-HCTI
Aug 13, 2026▲ +39.5%on this news
Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
Healthcare Triangle, Inc. reported impressive financial results for Q2 2026, showcasing a 158% increase in revenue and a 322% rise in gross profit compared to the previous year. The company's AI-powered customer engagement segment significantly contributed to these results, accounting for 69% of total revenue. The successful acquisition of Teyame and Datono continues to drive growth, reflecting positively on the company's financial stability.
Read more →-HCTI
Aug 6, 2026▲ +10.2%on this news
HCTI's Teyame Delivers a Full Year of Client Revenue in Six Months; €2 Million in Target
Healthcare Triangle, Inc. (HCTI) announced that its subsidiary, Teyame Holdings, has achieved significant growth by matching its entire 2025 revenue in just six months. The client, a leading Spanish health insurance company, is projected to generate €2 million annually. This performance validates HCTI's recent acquisitions and reflects broader growth within the company's portfolio.
Read more →-HCTI
Jul 29, 2026▼ -26.6%on this news
Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets
Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent to acquire a 51% stake in CosmoInnovations, a Melbourne-based MedTech and consumer-health innovator. The deal, valued at $23.5 million, aims to enhance HCTI's product offerings and revenue potential. CosmoInnovations brings a robust patent portfolio and a projected revenue pipeline exceeding $50 million over three years. The acquisition marks a strategic shift for HCTI towards becoming a product-led innovation platform.
Read more →-HCTI
Jul 29, 2026Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard
Healthcare Triangle, Inc. has completed the issuance of over 12.5 million shares, enhancing its compliance with Nasdaq's new $5 million market value requirement. This increase follows two shareholder-approved transactions, including the acquisition of Teyame AI LLC. The company's market value now stands at approximately $23.87 million, bolstering its position for continued listing on Nasdaq.
Read more →-HCTI
Jul 27, 2026Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns
Healthcare Triangle, Inc. has appointed Sumit Ganguli as the Chairman and CEO of its subsidiary, Purpose Health, to enhance its AI-driven healthcare services. The company aims to capitalize on high-margin recurring revenue models while expanding its market presence in the U.S. and internationally. Ganguli's extensive experience in scaling healthcare technology businesses is expected to accelerate Purpose Health's growth and innovation.
Read more →-HCTI
Jun 12, 2026▼ -5.9%on this news
WallachBeth Capital Announces Closing of Healthcare Triangle, Inc. Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million
WallachBeth Capital has successfully closed a private placement offering for Healthcare Triangle, Inc., raising approximately $3.6 million through senior convertible promissory notes. The notes, which mature in December 2026, are convertible at a price based on the company's stock performance. The proceeds will be allocated for debt repayment, potential acquisitions, and working capital.
Read more →-HCTI
Jun 12, 2026▼ -10.1%on this newsshared move
Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million
Healthcare Triangle, Inc. has announced the closing of a private placement offering of senior convertible promissory notes, raising approximately $3.6 million. The notes, maturing on December 12, 2026, are convertible at the holder's option after six months. Proceeds will be utilized for debt repayment, potential acquisitions, and general working capital.
Read more →-HCTI
May 14, 2026Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026
Healthcare Triangle, Inc. reported a remarkable 166% increase in revenue and a 627% rise in gross profit for Q1 2026, driven primarily by its recent acquisitions of Teyame 360 S.L. and Datono Mediacion S.L. These acquisitions contributed significantly to the company's financial performance, establishing a new Customer Engagement Services segment. Management anticipates continued improvements in gross margins as integration progresses.
Read more →-HCTI
Apr 23, 2026▼ -9.3%on this news
Healthcare Triangle, Inc. Launches AI-Driven Digital Self-Care Therapy Platform "ZoraNex" to address the $450B Global Mental Health Market
Healthcare Triangle, Inc. has launched ZoraNex, an AI-driven digital self-care therapy platform aimed at addressing the global mental health crisis. This platform combines Western and Eastern therapeutic practices to provide accessible mental health support for individuals experiencing mild to moderate issues. ZoraNex will be available on major app stores by the end of Q2 2026, targeting Southeast Asia as a key growth region.
Read more →-HCTI
Mar 11, 2026▲ +12.5%on this news
Healthcare Triangle, Inc. Announces Approval of $2 Million Share Repurchase Plan
Healthcare Triangle, Inc. has announced the approval of a $2 million share repurchase plan by its Board of Directors. The plan allows the company to buy back its outstanding common stock through various methods and is effective immediately. This move is aimed at enhancing shareholder value and demonstrates the Board's confidence in the company's long-term business strategy. Additionally, it provides the necessary flexibility to manage shares based on market conditions and corporate liquidity requirements.
Read more →-HCTI
Feb 26, 2026▼ -13.6%on this news· ran to -50% by day 3
Healthcare Triangle Announces Approximately
Healthcare Triangle, Inc. has announced a registered direct offering of 681,553 shares of common stock at a price of $5.81 per share. The offering is expected to generate gross proceeds of approximately $3.959 million and is set to close on February 27, 2026, pending customary closing conditions. This financing will enhance the company's position in the digital transformation space within healthcare and life sciences.
Read more →-HCTI
Feb 6, 2026▼ -28.8%on this news· ran to -39% by day 3
Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan
Healthcare Triangle, Inc. announced a 1-for-60 reverse stock split effective February 10, 2026, to comply with Nasdaq's $1.00 minimum bid price requirement. This measure, approved by shareholders, is expected to increase the stock price and align the company with exchange regulations. The split will reduce the number of outstanding shares and is part of a broader corporate strategy to enhance market performance.
Read more →About Healthcare Triangle, Inc.
Headquarters4309 HACIENDA DR., PLEASANTON, CA, 945888
BIOPHARMAWATCH ELITE PLUS
Trade the next HCTI catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime